Abbott Laboratories All Financial Data in US $ (mln)

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2018) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Company Profile

Profile Abbott Laboratories (ABT) is an Illinois based medical device company focused on the development of in-vitro diagnostics, cardiology, diabetic care and ophthalmic products.

01 JAN 2013: Abbott spun-out "AbbVie" as a new research-based pharmaceutical company.
Listed or Private Company Listed
Company Classification Generic; MedTech
Country USA
Company Website Website
Full Company Profile Information

EventAnalyzer - Last Key Event

Closing Price DateClosing Price Date EventAnalyzer Note Market Cap (US $m) Change (%) Change (+$m)
16/10/2013 16 Oct: Company's Q3'13 earnings beat expectations, driven by strong demand in its nutrition and diagnostics sectors, and helped by cost-cutting and lower taxes; company reiterates its FY 2013 revenue guidance and also raises its quarterly dividend by 57% to $0.22 per share, payable on 15 Feb 2014. 55,793 6.5% 3,403

Top 3 Products (Worldwide Sales)

Annual Sales WW - Sales Growth per Year (%)
Rank1 Product Generic Name Therapeutic Subcategory 2010
1 Humira adalimumab Other anti-rheumatics 6,5482
2 TriCor fenofibrate Anti-hyperlipidaemics 1,5823
3 Kaletra lopinavir; ritonavir Anti-virals 1,255

RX Sales Chart

Abbott Laboratories Data Growth
2010 2011 2011
 Revenues By Segment
     Pharmaceuticals Sales (In-depth)
       Rx & OTC Pharmaceuticals
         Prescription (Rx) Pharmaceuticals 19,8344 22,4185 +13%

Therapy Area Focus

Abbott Laboratories
 WW Rx & OTC Sales By Therapy Area
  Main Categories
     Blood 28
     Cardiovascular 3,409
     Central Nervous System 1,274
     Endocrine 1,132
     Gastro-Intestinal 678
     Genito-Urinary 1,317
     Musculoskeletal 7,932
     Oncology & Immunomodulators 810
     Respiratory 24
     Systemic Anti-Infectives 3,130
     Other Rx & OTC Pharma 2,683

EvaluatePharma® Coverage of Marketed and Pipeline Products

Product Count
Abbott Laboratories 6 589


Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.

Explore Evaluate


EvaluatePharma® now includes Partnering Opportunities - products available for licensing.

Partnering Opportunities in EvaluatePharma® are sourced from the rights holders - all entries are verified by the team of Analysts at EvaluatePharma - and presented in their commercial context.

Register to submit your Partnering Opportunities or to see your own and other Partnering Opportunities in their commercial context with the unique industry-wide analysis in EvaluatePharma®.

Take a full subscription to see all products available for license, including updated contact details for the out-licensing entity.

Register to access more FREE content:

  • 2011 Product Sales analysis
  • 2011 Pharmaceutical Sales
  • 2011 Market Share & Global Ranking
  • Download to Excel
  • Search 2 yrs of company press releases

Register for Free Analysis

Register to access more free insights and analysis from Evaluate.

Register Now